These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Spontaneous regression of degenerative retinoschisis associated with outer leaf retinal breaks. Clare G; Sullivan P; Gregor Z Retina; 2005 Dec; 25(8):1116-7. PubMed ID: 16340551 [No Abstract] [Full Text] [Related]
4. Spontaneous resolution of foveal cysts associated with X-linked retinoschisis as observed by optical coherence tomography. Jo YJ; Kim KN; Kim JY Can J Ophthalmol; 2010 Aug; 45(4):414-5. PubMed ID: 20648079 [No Abstract] [Full Text] [Related]
5. Spontaneous resolution of peripapillary retinoschisis associated with glaucomatous optic neuropathy. Inoue M; Itoh Y; Rii T; Kita Y; Hirota K; Kunita D; Hirakata A Acta Ophthalmol; 2015 Jun; 93(4):e317-8. PubMed ID: 25384451 [No Abstract] [Full Text] [Related]
6. Relation of lipid abnormalities to progression of renal damage in essential hypertension, insulin-dependent and non insulin-dependent diabetes mellitus. Walker WG Miner Electrolyte Metab; 1993; 19(3):137-43. PubMed ID: 8232100 [TBL] [Abstract][Full Text] [Related]
7. [The importance of metabolic control in type 2 diabetes mellitus]. Drzewoski J Pol Arch Med Wewn; 1999; 102 Spec No():37-44. PubMed ID: 10916625 [No Abstract] [Full Text] [Related]
8. Screening for type 2 diabetes mellitus in adults. Fink K; Clark B Am Fam Physician; 2004 Feb; 69(3):605-6. PubMed ID: 14971844 [No Abstract] [Full Text] [Related]
9. [A case of congenital retinoschisis with unexpected appearance and spontaneous regression]. Kageyama M; Nakatsuka K; Miyake Y Nippon Ganka Gakkai Zasshi; 1997 Aug; 101(8):698-702. PubMed ID: 9284627 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of hyperlipidemia in diabetes mellitus and hypertension]. Krone W Verh Dtsch Ges Inn Med; 1989; 95():636-8. PubMed ID: 2603499 [No Abstract] [Full Text] [Related]
12. [Risk factors for atherosclerosis in non-insulin-dependent diabetes]. Van Gaal LF; de Leeuw IH Journ Annu Diabetol Hotel Dieu; 1992; ():101-12. PubMed ID: 1495229 [No Abstract] [Full Text] [Related]
13. Olfactory dysfunction in type 2 diabetes mellitus: an additional manifestation of microvascular disease? Gouveri E; Katotomichelakis M; Gouveris H; Danielides V; Maltezos E; Papanas N Angiology; 2014 Nov; 65(10):869-76. PubMed ID: 24554429 [TBL] [Abstract][Full Text] [Related]
14. [Recommendations from an expert group: treatment of non-insulin-dependent diabetes mellitus]. Lakartidningen; 1990 Mar; 87(11):865-9. PubMed ID: 2179656 [No Abstract] [Full Text] [Related]
16. Evidence-based therapy for type 2 diabetes. The best and worst of times. Flemmer MC; Vinik AI Postgrad Med; 2000 May; 107(5):27-8, 31-4, 37-40, passim. PubMed ID: 10844940 [TBL] [Abstract][Full Text] [Related]
17. Regarding "prevalence of the metabolic syndrome in relation to self-reported cancer history". Polednak AP Ann Epidemiol; 2006 Dec; 16(12):877-9. PubMed ID: 16882474 [No Abstract] [Full Text] [Related]
18. [Prevalence of dyslipidaemia, hypertension and vascular complications in newly diagnosed diabetics (prospective study: part 2)]. Perusicová J Vnitr Lek; 2001 Mar; 47(3):146-50. PubMed ID: 15635875 [TBL] [Abstract][Full Text] [Related]
19. Insulin resistance: implications for Maori. Joseph N Pac Health Dialog; 2000 Mar; 7(1):122-3. PubMed ID: 11709874 [No Abstract] [Full Text] [Related]